3D Bioprinting Market based on by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Research, Clinical), End User (Biopharma, Academia) ,Regional Outlook– Global Forecast up to 2030

    Published: Jan 2024Report ID: 3BCHM1023128 Pages
    128
    Pages
    112
    Tables
    112
    Figures
    16
    Countries

    Report Summary

    Governments throughout the world are launching projects and sponsoring educational institutions, research centres, and research and technology organisations to further investigate and stimulate the development of 3D printing technology. The United States, the United Kingdom, and Canada have all launched government programmes aimed at fostering university-level 3D printing research, accelerating technological innovation, and establishing start-ups. The advent of novel uses for 3D printing has piqued the interest of businesses and governments worldwide. The UK National Strategy for Additive Manufacturing 2023-2030, for example, seeks to reach EUR 3,500 million in gross value added (GVA) per year by 2030, as well as 60,000 employment across industries. The plan represents a comprehensive set of proposals created by workgroups responsible for certain themes.

    Key Questions Answered in This Report

    • What are the key market trends and growth drivers?
    • Who are the major players and what are their market strategies?
    • What is the market size and forecast for the coming years?
    • What are the regional market dynamics and opportunities?

    Select License Type

    $4,500
    $5,000
    $5,500
    Category:Healthcare
    Industry:Healthcare
    Published:Jan 2024
    Pages:128